Pharmaceutical Industry News Archive
Get news By email or subscribe to our News feeds.
October 2008
October 1
October 2
Bayer's Novel Oral Anticoagulant Xarelto (Rivaroxaban) Gets European Licence
Watson Notified of OXYTROL Patent Challenge
Biotech Holdings Ltd. Announces Strategic Review Process
New Survey Reveals Consumers Wary of Prescription Switches
Merck Discontinues Development of Investigational Medicine Taranabant for Obesity
Physicians Interactive Acquired by Private Investment Firm Perseus L.L.C.
U.S. Food & Drug Administration Approved the use of REYATAZ (atazanavir sulfate) Boosted with Ritonavir, in Combination Therapy, for Previously Untreated HIV-1 Infected Adult Patients
PPD Completes Acquisition of InnoPharm
October 3
Genentech Issues Dear Healthcare Provider Letter Regarding a Reported Case of PML in a Raptiva Patient
Cardinal Health Resolves Controlled Substance License Suspensions
Severe Adverse Event Reported in Raptiva Patient
Cardinal Health Inc., Agrees to Pay $34 Million to Settle Claims That it Failed to Report Suspicious Sales of Widely-Abused Controlled Substances
District Court Affirms Patent Infringement Rulings and Finds That Amgen is Entitled to a Permanent Injunction against Roche
October 6
Ariad Announces Favorable Ruling Permitting Immediate Appeal of District Court Findings on NF-(kappa)B Patent in Amgen Litigation
Lilly to Acquire ImClone Systems in $6.5 Billion Transaction
Waterfront Media To Merge With Revolution Health Network Establishing The Everyday Health Network As The Preeminent Online Health Destination
Landmark COPD Trial UPLIFT Shows SPIRIVA HandiHaler Sustained Lung Function Improvements Over Four Years
Westaim enters into reorganization agreement valuing Westaim at $0.60 per share
October 7
Anti-Cancer Drug Prevents, Reverses Cardiovascular Damage In Mouse Model Of Premature Aging Disorder
Eli Lilly and Company Resolves Investigation Involving Numerous States
AtheroGenics Files for Chapter 11 Bankruptcy
MedWatch - Tiotropium (Spiriva): updated information on risk of stroke and reports of cardiovascular adverse outcomes
October 8
October 9
EpiCept Receives Ceplene Marketing Approval in Europe
Novo Nordisk Assigns Inhaled Insulin Patent Portfolio to Aradigm
Shionogi and Sciele Announce Completion of Subsequent Offering Period
Nventa Provides Corporate Update and Advancement Plans for HspE7, Hsp 6/11 and Poly-ICR
Boston Scientific Comments on Involuntary Selling of Its Stock by Co-Founders
Abbott Opens New Research Facility and Pilot Plant in Ludwigshafen
Canadian Vaccine Manufacturer Able to Deliver Doses Ahead of Schedule
AstraZeneca's Purplepill.com Tops the List of Most Visited Pharmaceutical Brand Web Sites in Q2 2008
Omrix Biopharmaceuticals Provides Update On Fibrin Pad U.S. Phase II Clinical Trial In Mild to Moderate Bleeding
October 10
FDA Continues Review of Takeda's New Drug Application for Alogliptin (SYR-322), a DPP-4 Agent for Type 2 Diabetes
Shionogi Completes Acquisition of Sciele
Nation's Teen Vaccination Coverage Increasing, But Below 2010 Goals
FDA Approves AstraZeneca’s Seroquel XR for the Treatment of Bipolar Depression and Bipolar Mania in the US
October 13
October 14
Lilly Commences Cash Tender Offer for ImClone Systems at $70 Per Share
Par Pharmaceutical Announces Resizing of Generic Unit to Optimize Strong First-to-File Pipeline
Manhattan Research Announces Top Condition Groups Shifting Their TV Viewing Online
Johnson & Johnson Reports 2008 Third-Quarter Results
October 15
Abbott Reports Strong Sales and Earnings Growth in Third Quarter; Again Raises Full-Year Earnings Outlook
Genentech Announces Third Quarter 2008 Results
Alcon Announces Two Agreements Designed to Expand Its Future Drug Portfolio
Emory Creates New Conflict Oversight, Announces New Disclosure Requirements
Wyeth Provides Regulatory Update Regarding Desvenlafaxine for the Treatment of Major Depressive Disorder
GSK’s Emerging Markets Strategy Advances With Acquisition in Egypt
ETHEX Corporation Voluntarily Recalls Three Lots of Dextroamphetamine Sulfate 5mg Tablets Due to the Potential for Oversized Tablets
October 16
FDA Grants Full Approval to Ontak (denileukin diftitox) for Use in Patients with Cutaneous T-Cell Lymphoma (CTCL)
Cell Genesys Announces Termination of VITAL-1 Phase 3 Trial of GVAX Immunotherapy for Prostate Cancer
Baxter Posts Strong Sales and Earnings for Third Quarter 2008
Dingell, Stupak Continue DTC Ad Investigation
Barr Says Court of Appeals Upholds 2005 District Court Decision on 1997 Cipro Settlement
October 17
FDA Approves Updated Labeling for Psoriasis Drug Raptiva
Pfizer Reaches Agreements in Principle to Resolve Litigation Involving Its NSAID Pain Medications
HHS Preparing to Open FDA Offices in China, India, Europe, and Latin America This Year
Plaintiffs' Counsel Comments On Settlement in Bextra Marketing, Sales Practices, and Product Liability Litigation
October 20
Novartis Delivers Sustained Strong Performance In First Nine Months Of 2008 Underpinned By Accelerating Growth In Pharmaceuticals
Adventrx Announces Restructuring and Cost Reduction Initiatives
HLTH Corporation and WebMD Health Corp. Announce Termination of Merger Agreement
Wisconsin Medical Society Board Passes New Physician Gift Policy
FDA Issues Draft Guidance on Priority Review Vouchers
October 21
Pfizer Reports Third-Quarter 2008 Results
Biogen Idec Reports Third Quarter 2008 Results
Schering-Plough Reports Financial Results for Third Quarter of 2008
Nektar Sells Pulmonary Business to Novartis For $115 Million and Nektar Retains Key Pulmonary Programs Including Amikacin Inhale, Inhaled Vancomycin, and Ciprofloxacin Inhalation Powder
Myriad Genetics Announces Plan to Separate Into Two Independent Public Companies
Novartis to Acquire Nektar Therapeutics Pulmonary Business Unit, Strengthening Respiratory Drug Delivery Capabilities
Forest Laboratories, Inc. Reports Fiscal Second Quarter 2009 Earnings per Share of $0.80
Kyowa Hakko Kirin Revises Down Profit Forecasts: Full Year Sales Forecast Unchanged
Trimeris Reports Third Quarter 2008 Fuzoeon Sales Results
Lilly to Take Charge to Earnings Related to Pending Federal and State Investigations of Past Practices
Study Documents Safety Problems for Biological Products
October 22
Pfizer Names New Head of Clinical Development and Medical Affairs for Its Oncology Business Unit
Wyeth Reports Earnings Results for the 2008 Third Quarter and First Nine Months
Merck Reports Third-Quarter 2008 Financial Results
Dynavax and Merck & Co., Inc. Provide Update on U.S. FDA Clinical Hold on Investigational Vaccine HEPLISAV(TM)
Everyday Health Network Enters Content Alliance with Yahoo!
Genzyme Reports Strong Third-Quarter Sales and Earnings Growth
GSK delivers Q3 business performance EPS of 25.2p and increased dividend of 14p
Pfizer Completes Settlement Agreements with State Attorneys General Regarding its NSAID Pain Medications
Better Data Management and More Inspections Are Needed to Strengthen FDA’s Foreign Drug Inspection Program
October 23
Alcon's Third Quarter Sales Rise 14.1 Percent
Lilly Reports Third-Quarter Results
New Hope for Multiple Sclerosis Sufferers
Bristol-Myers Squibb Continues Excellent Financial Performance Led By Double-Digit Global Net Sales Growth and Strong Earnings Results
GlaxoSmithKline and Affiris Sign an Exclusive Licence and Option Agreement for Therapeutic Alzheimer's Disease Candidate Vaccines
Maxygen Announces Plans to Reduce Spending and Revise Corporate Strategy
Publicis Healthcare Communications Group (PHCG) Acquires Reed Weir Communications Strengthening its Offering in Australia and APAC
New President Named at Dorland Global Public Relations
First Centralised Authorisation To Be Moved To Non-Prescription Status
October 24
October 27
October 28
Meta-Analysis Examines Cardiovascular Effects of Diabetes Medications
Researchers: Strengthen Restrictions on Off-Label Promotion by Pharmaceutical Companies
Costlier New Diabetes Drugs Don't Necessarily Produce Better Outcomes, Stanford Researcher Says
How Drug Companies Covertly Promote Off-Label Drug Use
Credit Crunch Threatens New Medicines
First Online Drug Alerts Go to U.S. Doctors
Harvest Technologies Announces Patient Education Website, www.CLIclinicalstudy.com
October 29
FDA Awards NIPTE $1.19 Million Contract to Develop Quality by Design (QbD) Guidance Elements
Bayer Optimistic About Future Business Trend
Merck KGaA Announces Collaboration and Licensing Agreement with Theratechnologies for Tesamorelin in the United States
IMS Health Forecasts 4.5 - 5.5 Percent Growth for Global Pharmaceutical Market in 2009, Exceeding $820 Billion
Allergan Reports Third Quarter 2008 Operating Results
Shire's New Product Portfolio Delivers Strong Quarterly Performance
Growing Number of Consumers Trust Online Resources Over Other Media for Researching Drug Treatment Information – Prospectiv Survey Reveals
October 30
GlaxoSmithKline to Acquire Genelabs Technologies to Increase Focus on Novel Small Molecule Therapies for Hepatitis C
AstraZeneca PLC:Third Quarter and Nine Months Results 2008
FDA Sends Letter to Amgen Over Sensipar DTC Brochure
Americans Dissatisfied with Healthcare, Want Lower Costs Even if it Means Sacrificing Quality According to New QualityHealth.com Survey
